Published in Biochemistry on June 29, 1993
Concern Crystal structure of human apolipoprotein A-I: insights into its protective effect against cardiovascular diseases. Proc Natl Acad Sci U S A (2006) 1.92
Apolipoprotein A-I helical structure and stability in discoidal high-density lipoprotein (HDL) particles by hydrogen exchange and mass spectrometry. Proc Natl Acad Sci U S A (2012) 1.00
Nanotechnology for synthetic high-density lipoproteins. Trends Mol Med (2010) 0.86
Role of apolipoprotein A-II in the structure and remodeling of human high-density lipoprotein (HDL): protein conformational ensemble on HDL. Biochemistry (2012) 0.85
The lipid composition of high-density lipoprotein affects its re-absorption in the kidney by proximal tubule epithelial cells. Biochem J (2004) 0.77
Structural Insights into High Density Lipoprotein: Old Models and New Facts. Front Pharmacol (2016) 0.77
High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase. Nat Med (2001) 2.61
Increased expression of inducible nitric oxide synthase and cyclo-oxygenase-2 in the airway epithelium of asthmatic subjects and regulation by corticosteroid treatment. Thorax (2001) 1.95
Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins. Nature (1989) 1.91
The receptor-binding domain of human apolipoprotein E. Monoclonal antibody inhibition of binding. J Biol Chem (1983) 1.67
Human apolipoprotein E. Determination of the heparin binding sites of apolipoprotein E3. J Biol Chem (1986) 1.50
Antimicrobial activity of flavonoids from leaves of Tagetes minuta. J Ethnopharmacol (1997) 1.49
Mapping of antigenic determinants of human apolipoprotein B using monoclonal antibodies against low density lipoproteins. J Biol Chem (1982) 1.47
Characterization of monoclonal antibodies against human low density lipoprotein. Arteriosclerosis (1983) 1.44
The use of monoclonal antibodies to localize the low density lipoprotein receptor-binding domain of apolipoprotein B. J Biol Chem (1989) 1.41
Molecular cloning and expression of partial cDNAs and deduced amino acid sequence of a carboxyl-terminal fragment of human apolipoprotein B-100. Proc Natl Acad Sci U S A (1985) 1.35
Apolipoprotein A-I: structure-function relationships. J Lipid Res (2000) 1.31
Use of bacterial expression cloning to localize the epitopes for a series of monoclonal antibodies against apolipoprotein B100. J Biol Chem (1990) 1.30
Contamination of blood stored in plastic packs. Lancet (1970) 1.23
A plasticizer in lipid extracts of human blood. Chem Phys Lipids (1970) 1.18
Monoclonal antibody inhibition of cholesteryl ester transfer protein activity in the rabbit. Effects on lipoprotein composition and high density lipoprotein cholesteryl ester metabolism. J Clin Invest (1989) 1.16
Atherogenic diet increases cholesteryl ester transfer protein messenger RNA levels in rabbit liver. J Clin Invest (1990) 1.15
Monoclonal antibodies to the Mr 74,000 cholesteryl ester transfer protein neutralize all of the cholesteryl ester and triglyceride transfer activities in human plasma. J Biol Chem (1988) 1.15
Truncated variants of apolipoprotein B cause hypobetalipoproteinaemia. Nucleic Acids Res (1988) 1.13
Apolipoprotein D transcription occurs specifically in nonproliferating quiescent and senescent fibroblast cultures. FEBS Lett (1991) 1.08
Contribution of apoB-48 and apoB-100 triglyceride-rich lipoproteins (TRL) to postprandial increases in the plasma concentration of TRL triglycerides and retinyl esters. J Lipid Res (1993) 1.07
Mapping of human apolipoprotein B antigenic determinants. Arteriosclerosis (1987) 1.07
Apoprotein B structure and receptor recognition of triglyceride-rich low density lipoprotein (LDL) is modified in small LDL but not in triglyceride-rich LDL of normal size. J Biol Chem (1994) 1.07
Characterization of monoclonal antibodies against human apolipoprotein E. J Clin Invest (1981) 1.06
Binding of chylomicron remnants and beta-very low density lipoproteins to hepatic and extrahepatic lipoprotein receptors. A process independent of apolipoprotein B48. J Biol Chem (1984) 1.05
Production of antimicrobials by Bacillus subtilis MIR 15. J Biotechnol (1992) 1.04
Reduction in the concentration and activity of plasma cholesteryl ester transfer protein by alcohol. J Lipid Res (1992) 1.03
Antimicrobial activity determined in strains of Bacillus circulans cluster. Folia Microbiol (Praha) (1993) 1.02
Plasma concentrations of cholesteryl ester transfer protein in hyperlipoproteinemia. Relation to cholesteryl ester transfer protein activity and other lipoprotein variables. Arterioscler Thromb (1991) 1.01
Isolation and characterization of apolipoprotein B-48 and B-100 very low density lipoproteins from type III hyperlipoproteinemic subjects. J Clin Invest (1984) 1.00
Apolipoprotein A-I conformation in reconstituted discoidal lipoproteins varying in phospholipid and cholesterol content. J Biol Chem (1995) 1.00
Cholesteryl ester transfer protein and high density lipoprotein responses to cholesterol feeding in men: relationship to apolipoprotein E genotype. J Lipid Res (1993) 1.00
Transfer of cholesterol esters between human high density lipoproteins and triglyceride-rich lipoproteins controlled by a plasma protein factor. Atherosclerosis (1980) 0.99
Increase in plasma cholesteryl ester transfer protein during probucol treatment. Relation to changes in high density lipoprotein composition. Arterioscler Thromb (1991) 0.99
Epitopes of apolipoprotein B-100 and B-48 in both liver and intestine. Expression and evidence for local synthesis in recessive abetalipoproteinemia. J Clin Invest (1986) 0.99
Lecithin: cholesterol acyltransferase of human plasma. Role of chylomicrons, very low, and high density lipoproteins in the reaction. J Biol Chem (1973) 0.98
Magnetic properties of ZnO nanoparticles. Nano Lett (2007) 0.98
Mapping apolipoprotein B on the low density lipoprotein surface by immunoelectron microscopy. J Biol Chem (1991) 0.97
Mechanism of cholesteryl ester transfer protein inhibition by a neutralizing monoclonal antibody and mapping of the monoclonal antibody epitope. J Biol Chem (1989) 0.96
Preparative isoelectric focussing of apolipoproteins C and E from human very low density lipoproteins. Biochim Biophys Acta (1979) 0.96
Lupus anticoagulant and antiplatelet properties of human hybridoma autoantibodies. J Immunol (1987) 0.96
Serum albumin is a significant intermediate in cholesterol transfer between cells and lipoproteins. Biochemistry (1996) 0.96
Effects of ozone on epithelium and sensory nerves in the bronchial mucosa of healthy humans. Am J Respir Crit Care Med (1997) 0.95
Deletion of the C-terminal domain of apolipoprotein A-I impairs cell surface binding and lipid efflux in macrophage. Biochemistry (1999) 0.95
Cholesteryl ester and apolipoprotein E transfer between human high density lipoproteins and chylomicrons. Biochim Biophys Acta (1983) 0.94
Inhibition of cholesteryl ester transfer protein activity by monoclonal antibody. Effects on cholesteryl ester formation and neutral lipid mass transfer in human plasma. J Clin Invest (1989) 0.94
Structural relationship of human apolipoprotein B48 to apolipoprotein B100. J Clin Invest (1987) 0.93
Effects of postprandial lipemia on plasma cholesterol metabolism. J Clin Invest (1985) 0.93
Cutaneous xanthoma in association with paraproteinemia in the absence of hyperlipidemia. J Clin Invest (1989) 0.92
Secondary structure of human apolipoprotein A-I(1-186) in lipid-mimetic solution. FEBS Lett (2001) 0.92
Effect of apolipoprotein A-I lipidation on the formation and function of pre-beta and alpha-migrating LpA-I particles. Biochemistry (1999) 0.91
Determination of di-2-ethylhexyl phthalate levels in human blood plasma and cryoprecipitates. Environ Health Perspect (1973) 0.90
Biosynthesis of emulsan biopolymers from agro-based feedstocks. J Appl Microbiol (2007) 0.90
Evidence for the distribution of apolipoprotein E between lipoprotein classes in human normocholesterolemic plasma and for the origin of unassociated apolipoprotein E (Lp-E). J Lipid Res (1984) 0.89
Apolipoproteins as the basis for heterogeneity in high-density lipoprotein2 and high-density lipoprotein3. Studies by isoelectric focusing on agarose films. Eur J Biochem (1984) 0.89
The preferred metabolic pathway from linoleic acid to arachidonic acid in vitro. Biochim Biophys Acta (1968) 0.88
Cholesterol ester exchange between human plasma high and low density lipoproteins mediated by a plasma protein factor. Atherosclerosis (1978) 0.88
Modulation of apolipoprotein B antigenic determinants in human low density lipoprotein subclasses. J Biol Chem (1985) 0.88
The amphipathic alpha-helical repeats of apolipoprotein A-I are responsible for binding of high density lipoproteins to HepG2 cells. J Biol Chem (1991) 0.88
Heterogeneity of human high density lipoprotein: presence of lipoproteins with and without apoE and their roles as substrates for lecithin:cholesterol acyltransferase reaction. Proc Natl Acad Sci U S A (1980) 0.88
Plasma phospholipids in the different types of primary hyperlipoproteinemia. J Lab Clin Med (1972) 0.88
Binding of phospholipid transfer protein (PLTP) to apolipoproteins A-I and A-II: location of a PLTP binding domain in the amino terminal region of apoA-I. J Lipid Res (1998) 0.87
Influence of caveolin-1 on cellular cholesterol efflux mediated by high-density lipoproteins. Am J Physiol Cell Physiol (2001) 0.87
A method for the determination of the initial rate of reaction of lecithin: cholesterol acyltransferase in human plasma. Biochim Biophys Acta (1973) 0.87
Apolipoprotein D and cross-reacting human plasma apolipoproteins identified using monoclonal antibodies. J Biol Chem (1986) 0.87
Expression of low and high density lipoprotein receptor genes in human adrenals. Eur J Endocrinol (2000) 0.87
Detection of endothelial cell-reactive immunoglobulin in patients with anti-phospholipid antibodies. Br J Haematol (1991) 0.87
Structure of the human apolipoprotein D gene promoter region. Biochim Biophys Acta (1993) 0.87
Characterization of antigenic determinants of human apolipoprotein B. Distribution on tryptic fragments of low density lipoprotein. Arteriosclerosis (1984) 0.86
Proteolytic degradation and impaired secretion of an apolipoprotein A-I mutant associated with dominantly inherited hypoalphalipoproteinemia. J Biol Chem (2001) 0.86
Characterization of human apolipoprotein A-I expressed in Escherichia coli. Biochim Biophys Acta (1997) 0.85
Distinct central amphipathic alpha-helices in apolipoprotein A-I contribute to the in vivo maturation of high density lipoprotein by either activating lecithin-cholesterol acyltransferase or binding lipids. J Biol Chem (2000) 0.85
The N-terminal globular domain and the first class A amphipathic helix of apolipoprotein A-I are important for lecithin:cholesterol acyltransferase activation and the maturation of high density lipoprotein in vivo. J Biol Chem (2001) 0.85
Localization of the major sites of rabbit apolipoprotein D gene transcription by in situ hybridization. J Lipid Res (1991) 0.85
VLDL compositional changes and plasma levels of triglycerides and high density lipoprotein. Clin Chim Acta (1998) 0.85
Apolipoprotein distribution in human lipoproteins separated by polyacrylamide gradient gel electrophoresis. J Lipid Res (1988) 0.85
Alterations in the main steps of reverse cholesterol transport in male patients with primary hypertriglyceridemia and low HDL-cholesterol levels. Atherosclerosis (2000) 0.84
Apolipoprotein A-I binds to a family of bovine seminal plasma proteins. J Biol Chem (1989) 0.84
Adipose tissue cholesteryl ester transfer protein mRNA in response to probucol treatment: cholesterol and species dependence. J Lipid Res (1993) 0.84
Apolipoprotein A-I domains involved in the activation of lecithin:cholesterol acyltransferase. Importance of the central domain. J Biol Chem (1993) 0.84
Lecithin: cholesterol acyltransferase and intravascular cholesterol transport. Adv Lipid Res (1982) 0.83
Absence of intestinal synthesis of apolipoprotein B-48 in two cases of abetalipoproteinemia. Gastroenterology (1987) 0.83
Effect of a neutralizing monoclonal antibody to cholesteryl ester transfer protein on the redistribution of apolipoproteins A-IV and E among human lipoproteins. J Lipid Res (1989) 0.83
Monoclonal antibodies distinguish between lipid-dependent and reversible conformational states of human apolipoprotein B. Mol Immunol (1987) 0.83
Phosphatidylinositol-specific phospholipase C activity in Lactobacillus rhamnosus with capacity to translocate. FEMS Microbiol Lett (2001) 0.83
Kinetic studies on the specificity of long chain acyl coenzyme A synthetase from rat liver microsomes. J Biol Chem (1972) 0.83
Lipid and lipoprotein secretion following portacaval shunt in swine. Atherosclerosis (1978) 0.82
Characterization of antigenic determinants on human solubilized apolipoprotein B. Conformational requirements for lipids. J Biol Chem (1984) 0.82
Two distinct pathways of interferon induction as revealed by 2-aminopurine. Nucleic Acids Res (1992) 0.82
Specificity of long-chain acyl coenzyme A synthetase from rat liver microsomes. Influence of the position of double bonds in octadecadienoic acids. Biochemistry (1972) 0.82
Monoclonal antibodies against human low density lipoprotein. Stoichiometric binding studies using Fab fragments. FEBS Lett (1982) 0.82
Immunoreactive endothelin in bronchial biopsy specimens: increased expression in asthma and modulation by corticosteroid therapy. J Allergy Clin Immunol (1997) 0.82
Uptake of high density lipoprotein cholesterol ester by HepG2 cells involves apolipoprotein E localized on the cell surface. J Biol Chem (1993) 0.82
Studies on the polymorphism of human apolipoprotein A-I. Biochim Biophys Acta (1980) 0.82
Effect of the apolipoprotein A-I and surface lipid composition of reconstituted discoidal HDL on cholesterol efflux from cultured fibroblasts. Biochemistry (1996) 0.82
Importance of central alpha-helices of human apolipoprotein A-I in the maturation of high-density lipoproteins. Biochemistry (1998) 0.82
Apolipoprotein D--an atypical apolipoprotein. Prog Lipid Res (1991) 0.81
Cu2(+)-mediated oxidation of dialyzed plasma: effects on low and high density lipoproteins and cholesteryl ester transfer protein. J Lipid Res (1991) 0.81
An integrin-targeted non-viral vector for pulmonary gene therapy. Gene Ther (2000) 0.81
The linkage with apolipoprotein (a) in lipoprotein (a) modifies the immunochemical and functional properties of apolipoprotein B. Biochemistry (1988) 0.81